GRAIL (NASDAQ:GRAL) President Joshua Ofman Sells 6,114 Shares of Stock

GRAIL, Inc. (NASDAQ:GRAL) President Joshua Ofman sold 6,114 shares of the firm’s stock in a transaction dated Thursday, October 16th. The stock was sold at an average price of $82.01, for a total value of $501,409.14. Following the completion of the transaction, the president owned 381,818 shares in the company, valued at approximately $31,312,894.18. This trade represents a 1.58% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

GRAIL Price Performance

GRAIL stock opened at $86.41 on Friday. The stock’s 50-day moving average is $45.29 and its 200-day moving average is $39.72. The company has a market cap of $3.12 billion, a price-to-earnings ratio of -6.59 and a beta of 4.11. GRAIL, Inc. has a 12 month low of $12.76 and a 12 month high of $89.57.

GRAIL (NASDAQ:GRAL) last released its quarterly earnings data on Tuesday, August 12th. The company reported ($3.18) EPS for the quarter, missing analysts’ consensus estimates of ($3.14) by ($0.04). The firm had revenue of $35.54 million during the quarter, compared to analysts’ expectations of $37.57 million. GRAIL had a negative return on equity of 16.64% and a negative net margin of 329.86%. Research analysts anticipate that GRAIL, Inc. will post -15.15 EPS for the current year.

Institutional Investors Weigh In On GRAIL

Hedge funds have recently bought and sold shares of the business. KBC Group NV grew its stake in GRAIL by 187.7% during the 1st quarter. KBC Group NV now owns 1,430 shares of the company’s stock valued at $37,000 after purchasing an additional 933 shares in the last quarter. S.A. Mason LLC grew its stake in GRAIL by 50.1% during the 1st quarter. S.A. Mason LLC now owns 1,499 shares of the company’s stock valued at $38,000 after purchasing an additional 500 shares in the last quarter. Farther Finance Advisors LLC grew its stake in GRAIL by 768.1% during the 2nd quarter. Farther Finance Advisors LLC now owns 816 shares of the company’s stock valued at $42,000 after purchasing an additional 722 shares in the last quarter. NewEdge Advisors LLC grew its stake in GRAIL by 390.3% during the 1st quarter. NewEdge Advisors LLC now owns 1,760 shares of the company’s stock valued at $45,000 after purchasing an additional 1,401 shares in the last quarter. Finally, Signaturefd LLC grew its stake in GRAIL by 273.0% during the 1st quarter. Signaturefd LLC now owns 1,876 shares of the company’s stock valued at $48,000 after purchasing an additional 1,373 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently commented on GRAL shares. Weiss Ratings restated a “sell (d-)” rating on shares of GRAIL in a report on Wednesday, October 8th. Canaccord Genuity Group raised their target price on GRAIL from $43.00 to $75.00 and gave the company a “buy” rating in a report on Friday, October 3rd. Finally, UBS Group set a $75.00 target price on GRAIL in a report on Friday, October 3rd. One research analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, GRAIL has an average rating of “Hold” and an average price target of $56.67.

About GRAIL

GRAIL, Inc operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T.